Remus Pharmaceuticals Limited (NSE:REMUS)
India · Delayed Price · Currency is INR 961.65
+11.85 (1.25%)
Aug 21, 2026, 3:29 PM IST
Remus Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 8,536 | 8,536 | 6,204 | 2,129 | 451.32 | 247.17 |
Revenue Growth | 14.13% | 37.60% | 191.33% | 371.81% | 82.59% | 31.42% |
Gross Profit Gross Profit Growth | 1,114 | 1,114 | 873.9 | 494.6 | 236.63 | 124.36 |
Operating Income Operating Income Growth | 539.3 | 539.3 | 438.2 | 278.4 | 106.71 | 42.26 |
Net Income Net Income Growth | 369.9 | 369.9 | 290.7 | 205.2 | 85.03 | 34.34 |
Earnings Per Share EPS Growth | 39.19 | 39.19 | 24.67 | 18.16 | 10.41 | 4.29 |
EPS Growth | 43.20% | 58.86% | 35.85% | 74.43% | 142.51% | 234.77% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
India India Growth | 2,762 | 718.6 | 10.73 | 15.55 |
Latin America and The Caribbean Latin America and The Caribbean Growth | 677.6 | 552.5 | - | - |
Europe Europe Growth | 405 | 75.8 | - | - |
Middle East Middle East Growth | 13.7 | 18.3 | - | - |
Africa Africa Growth | 23.6 | - | - | - |
Asia Asia Growth | 1,097 | 154.4 | - | - |
North America North America Growth | 1,225 | 609.8 | - | - |
Total Total Growth | 6,204 | 2,129 | 450.27 | 247.17 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 549.1 | 549.1 | 272.7 | 249.6 | 30.38 | 11.49 |
Total Debt Total Debt Growth | 270.7 | 270.7 | 229.8 | 142.3 | 79.43 | 1.92 |
Net Cash (Debt) Net Cash Growth | 278.4 | 278.4 | 42.9 | 107.3 | -49.05 | 9.57 |
Net Cash Growth | 72.60% | 548.95% | -60.02% | - | - | 73.48% |
Net Cash Per Share Net Cash Per Share Growth | 29.50 | 29.50 | 3.64 | 9.50 | -6.00 | 1.20 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 181.6 | 181.6 | 69.8 | 13.5 | 53.13 | 50.38 |
Capital Expenditures CapEx Growth | -145.7 | -145.7 | -39.8 | -32.9 | -27.32 | -0.71 |
Free Cash Flow Free Cash Flow Growth | 35.9 | 35.9 | 30 | -19.4 | 25.81 | 49.67 |
Free Cash Flow Growth | 60.27% | 19.67% | - | - | -48.03% | 79.21% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 13.05% | 13.05% | 14.09% | 23.23% | 52.43% | 50.31% |
Operating Margin | 6.32% | 6.32% | 7.06% | 13.07% | 23.64% | 17.10% |
Pretax Margin | 6.93% | 6.93% | 7.63% | 14.16% | 25.29% | 18.66% |
Profit Margin | 4.33% | 4.33% | 4.69% | 9.64% | 18.84% | 13.89% |
FCF Margin | 0.42% | 0.42% | 0.48% | -0.91% | 5.72% | 20.09% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 1.000 | 1.000 | 0.750 | 0.750 | 0.250 |
Dividend Per Share Growth | 0% | 33.33% | 0% | 200.00% | - |
Dividend Yield | 0.11% | 0.16% | 0.07% | 0.09% | - |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 24.54 | 19.79 | 45.38 | 49.53 | - | - |
P/FCF Ratio | 312.28 | 203.90 | 439.73 | - | - | - |
PS Ratio | 1.31 | 0.86 | 2.13 | 4.77 | - | - |